Aura Biosciences, Inc.

Direct answer

Aura Biosciences, Inc. is publicly traded on NASDAQ under the ticker AURA.

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary virus-like drug conjugate (VDC) technology platform to address tumors with significant unmet medical needs, specifically in ocular (eye) and urologic oncology. Its flagship therapeutic candidate, AU-011, is a VDC...

Can you invest in Aura Biosciences, Inc.?

Yes. Aura Biosciences, Inc. is publicly traded on NASDAQ under the ticker AURA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Aura Biosciences, Inc.

Detailed equity research is provided by MarketSnap.